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The relationship between transdiagnostic, dimensional, 
and categorical approaches to psychiatric nosology is 
under intense debate. To inform this discussion, we studied 
neural systems linked to reward anticipation across a range 
of disorders and behavioral dimensions. We assessed brain 
responses to reward expectancy in a large sample of 221 
participants, including patients with schizophrenia (SZ; 
n = 27), bipolar disorder (BP; n = 28), major depressive 
disorder (MD; n = 31), autism spectrum disorder (ASD; 
n  =  25), and healthy controls (n  =  110). We also char-
acterized all subjects with an extensive test battery from 
which a cognitive, affective, and social functioning factor 
was constructed. These factors were subsequently related 
to functional responses in the ventral striatum (vST) and 
neural networks linked to it. We found that blunted vST 
responses were present in SZ, BP, and ASD but not in 
MD. Activation within the vST predicted individual differ-
ences in affective, cognitive, and social functioning across 
diagnostic boundaries. Network alterations extended be-
yond the reward network to include regions implicated in 
executive control. We further confirmed the robustness of 
our results in various control analyses. Our findings sug-
gest that altered brain responses during reward anticipa-
tion show transdiagnostic alterations that can be mapped 
onto dimensional measures of functioning. They also high-
light the role of executive control of reward and salience 
signaling in the disorders we study and show the power of 
systems-level neuroscience to account for clinically rele-
vant behaviors.
Key words:  dimensional/transdiagnostic/reward 
anticipation/fMRI/ventral striatum/salience
Introduction
Alterations in reward sensitivity or reinforcement-
dependent learning play a key role in psychiatric dis-
orders. Previous research has focused on schizophrenia 
(SZ) where altered brain responses during the anticipa-
tion of reward, in particular in the ventral striatum (vST), 
are well established.1 However, a growing number of 
studies reported network alterations during reward antic-
ipation in other disorders,2–4 including major depression 
(MD),5,6 bipolar disorder (BP),7 and autism spectrum dis-
order (ASD),8 mirroring the significant overlap between 
these disorders in symptomatology and genetic risk ar-
chitecture.9 In this sense, reward anticipation is a prime 
example of the current discussion whether categorical 
diagnoses should be supplemented, or even supplanted, 
by dimensional constructs linked to function.
Accordingly, recent studies have associated striatal 
brain responses during reward anticipation to dimensional 
concepts like anhedonia, depressive symptom severity, or 
psychotic symptoms across psychiatric conditions.3,4,10,11 
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These approaches highlight the potential of neuroim-
aging biomarkers in explaining brain-behavior relation-
ships in a more dimensional and inclusive way, ie, by 
means of shared psychological or symptom domains and 
beyond traditional definitions of health and disease.12,13 If  
established, such markers would allow the investigation 
of brain-behavior relationships independent of clinical 
status and diagnostic entity, thereby enhancing our cur-
rent categorical understanding of mental disorders and 
their neurobiological representation to a more dimen-
sional framework, from which valuable clues for therapy 
research may arise.
Building on these recent approaches, we investigated the 
transdiagnostic relevance of reward signaling in 2 ways. 
First, while previous studies of this system have usually in-
vestigated single behavioral domains in restricted groups 
of disorders, we performed a broad (neuro)psychological 
characterization to generate independent, data-driven 
factors that converge on underlying traits or states in a 
range of participants with serious mental illness along 
the moods-psychosis spectrum (SZ, BP, MD, and ASD). 
While exploratory in nature, these factors were expected 
to map on cognitive, affective, and social functioning, 
given our selection of tests and questionnaires. Second, 
previous research oftentimes studied the vST in isolation, 
often combined with disorder-specific hypotheses about 
underlying mechanisms (eg, dopamine hypothesis of 
SZ14). However, it is clear that the vST participates in sev-
eral extended networks or loops linked to a range of cogni-
tive, affective, and social behaviors.15,16 Alterations on the 
circuit-level can be studied using functional connectivity, 
which examines correlations in activity across regions. To 
date, several studies have reported alterations in cortico-
striatal connectivity in SZ (eg, 17) and other diagnostic 
entities (eg, BP,18 MD,19 and ASD20). However, their joint 
interpretation is hampered by methodological differences 
(eg, resting state vs task-based functional magnetic reso-
nance imaging [fMRI]), and transdiagnostic research on 
brain-behavior relationships is scarce (eg, 21). Accordingly, 
we aimed to identify reward-related alterations in dis-
tributed neural networks linked to the vST between and 
across diagnostic categories. We expected reward-related 
functional alterations to involve brain circuits beyond the 
vST. We also expected a relationship of transdiagnostic 
alterations with dimensional measures, based on evidence 
of an association with affective measures,3,4 the relevance 
of cognitive control for the processing of motivationally 
relevant cues,22 and the inherently motivational salience of 
social stimuli.23
In addition, we anticipated experimental challenges 
that arise in clinical imaging research, in particular when 
investigating different patient groups in the same study. 
We, therefore, carefully considered various factors related 
to clinical characteristics24 (eg, comorbidities and medi-
cation) and data quality issues (eg, motion artifacts and 
test–retest reliability) in several control analyses.
Methods
Sample
This study recruited a prospective new sample of 279 
subjects. All individuals provided written informed con-
sent for a study protocol approved by the institutional 
review board of the Medical Faculty Mannheim. After 
quality assurance procedures, the final sample included 
221 participants (Table 1). Patients were recruited from 
inpatient and outpatient treatment facilities. Healthy 
subjects were recruited from the local community by ad-
vertisement. Psychiatric diagnoses were confirmed by 
trained clinical interviewers using the Structured Clinical 
Interview for DSM-IV interview25 for all patient groups 
and the Autism Diagnostic Observation Schedule Module 
4 (ADOS-G26) for ASD patients. Patients with BP type 2 
were excluded. See Supplementary Material for details.
(Neuro)Psychological Characterization
Testing was performed by trained examiners using a bat-
tery of well-established tests for intellectual abilities in-
cluding reasoning, attention, verbal fluency, episodic 
memory, and working memory. Affective state and trait 
measures, questionnaires on personality characteristics 
and social functioning were acquired by online question-
naires. See Supplementary Material for details.
Neuroimaging Paradigm
We used an adapted version of the well-established incen-
tive delay task involving monetary27,28 and social reward29 
during fMRI and 2 conditions (cue win and cue neutral), 
with fair-to-good reliability of reward-network activation 
(see Supplementary Material for detailed information on 
test–retest reliability). We did not differentiate between 
reward types based on previous evidence of overlapping 
neural substrates,30 which we similarly demonstrate in our 
control analyses (see Supplementary Material). The anal-
ysis of mean reaction times and outcome measures re-
vealed no group differences (all P > .146; Table 1), which 
suggests that all subjects understood and engaged in the 
task equally well. See Supplementary Material for details.
MRI Data Acquisition and Preprocessing
Functional images were acquired using an echo-planar 
imaging sequence on a 3-T scanner (Siemens Trio) and 
preprocessed using standard routines in SPM12 (http://
www.fil.ion.ucl.ac.uk/spm/). See Supplementary Material 
for details.
First-Level Analyses
Functional activation during reward anticipation was as-
sessed as differential response to win cues as compared to 
neutral cues using first-level general linear model (GLM) 
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contrast images (win cue > neutral cue). Functional con-
nectivity was assessed using a seeded connectivity ap-
proach with individual GLMs for the first eigenvariate 
of the time series extracted from the right vST. See 
Supplementary Material for details.
Second-Level Analyses
Categorical Between-Group Analyses. To study reward 
network (dys)function between diagnostic entities, we 
conducted categorical analyses using individual con-
trast images for activation and functional connectivity 
and full-factorial designs with diagnostic group (HC, 
SZ, BP, MD, and ASD) as between-subject factor. As 
groups were naturally heterogeneous with respect to age, 
sex, and educational level, we included these variables as 
covariates of no interest in all analyses. In addition, de-
spite nonsignificant differences in head motion between 
groups (see table  1), we included mean framewise dis-
placement31 as covariate of no interest across analyses. In 
case of a significant main effect of group, F-tests were 
followed up by post hoc t-tests for group comparisons. 
Significance was assessed at the voxel-level and defined a 
priori as P < .05, familywise error (FWE) corrected within 
Table 1. Sample description
Group HC SZ BP MD ASD
Between- 
group differences
n 110 27 28 31 25  
Age 30.4 (10.3) 32.4 (10.4) 34.0 (9.6) 35.2 (11.2) 32.1 (9.6) F(4,216) = 2.12, 
P = .080
Sex (m/f) 54/56 18/9 12/16 8/23 14/11 χ 2(4) = 10.98, 
P = .027
Education (years) 12.4 (1.1) 11.1 (1.9) 12.3 (1.2) 11.7 (1.5) 11.9 (1.5) F(4,216) = 5.55,  
P ≤ .001
Education father (years) 10.9 (1.7) 10.6 (1.9) 10.3 (2.0) 10.4 (1.7) 11.1 (1.8) F(4,214) = 1.36, 
P = .250
Education mother (years) 10.8 (1.5) 10.5 (1.5) 10.2 (1.9) 10.3 (1.6) 10.6 (1.7) F(4,214) = 1.18, 
P = .320
Framewise displacement 0.2 (0.06) 0.2 (0.06) 0.2 (0.07) 0.2 (0.08) 0.2 (0.06) F(4,216) = 1.56, 
P = .185
Medication value — 2.8 (2.4) 2.6 (1.3) 1.7 (1.5) 0.4 (0.8) F(3,107) = 11.98,  
P ≤ .001
CPZ-e — 415.0 (45.2) 123.8 (42.7) 16.7 (41.3) 3.3 (47.1) F(3,102) = 13.66,  
P < .001
CGI — 4.35 (1.2) 3.46 (1.2) 3.75 (1.1) 3.5 (1.1) F(3,100) = 3.36, 
P = .022
Number of months of hospitalization 
during the last 2 years
0 2.9 (3.2) 1.6 (3.5) 1.5 (1.4) 0.4 (0.8) F(3,103) = 4.15, 
P = .008
PANSS — 54.6 (16.5) 41.0 (10.2) 46.5 (9.1) — F(2,82) = 8.27, 
P = .001
HAM-D — 7.8 (5.5) 8.0 (6.5) 13.2 (6.0) — F(2,82) = 7.64, 
P = .001
YMRS — 1.2 (2.4) 2.8 (3.7) 0.6 (1.2) — F(2,82) = 5.37, 
P = .006
ADOS — — — — 9.5 (2.8)  
Current MDa
 Not depressed 108 11 9 4 16  
 Mild 1 11 9 10 5  
 Moderate 0 5 6 10 3  
 Severe 0 0 4 7 0  
Reaction time (s) 239.9 (27.2) 238.3 (28.5) 242.5 (51.8) 244.9 (28.1) 253.3 (29.9) F(4,216) = 1.06, 
P = .146
Number of win trials (max 15) 10.3 (1.1) 10.3 (1.5) 10.0 (1.3) 10.5 (1.1) 9.8 (1.2) F(4,216) = 1.72, 
P = .380
Note: Displayed are mean values (SD) or numbers (male/female) and statistical between-group comparisons. For nonparametric test, we 
used the Kruskal–Wallis test (df = 5). For parametric tests, analysis of variance was computed. HC, healthy control; SZ, schizophrenia; 
BP, bipolar disorder, MD, major depression; ASD, autism spectrum disorder; m, male; f, female; CPZ-e, chlorpromazine dose equiva-
lents; CGI, Clinical Global Impression Scale57 (1: no mental disorder to 7: extreme mental disorder); PANSS, Positive and Negative 
Symptom Rating Scale58; HAMD-D, Hamilton Depression Scale59; YMRS, Young Mania Rating Scale60; ADOS, Autism Observation 
Schedule Module 4.26
aCurrent MD, current depressive state as assessed by the Beck Depression Inventory (BDI-II).61
D
ow
nloaded from
 https://academ
ic.oup.com
/schizophreniabulletin/advance-article-abstract/doi/10.1093/schbul/sbz075/5581768 by U
niversitaetsbibliothek Bern user on 04 N
ovem
ber 2019
Page 4 of 11
K. Schwarz et al 
a well-established mask of the vST32 (see Supplementary 
Material). Outside this mask, voxel-level significance was 
defined as PFWE < .05, corrected across the whole brain.
Dimensional Analyses. We further investigated whether 
interindividual differences in behavior can be mapped 
onto reward network functioning irrespective of diagnostic 
status. We performed a principal component analysis im-
plemented in SPSS (IBM, SPSS, version 23) to identify in-
dependent components or factors reflecting higher-order 
dimensions of (neuro)psychological functioning. The re-
sulting factors could be mapped onto dimensions of cog-
nitive, affective, and social functioning (see Supplementary 
Material for details). To identify associations of factors 
with functional brain responses, we first included individual 
factor loadings as covariates of interest in one-sample 
t-tests on brain activation and connectivity along with the 
above named covariates of no interest, without control-
ling for group. The same statistical thresholds were applied 
as outlined above. A second analysis step was performed 
for our vST region of interest to test whether individual 
factor loadings were predictive of neural responses beyond 
the effect of diagnostic category. We extracted peak-voxel 
estimates within significant activation clusters identified 
in the previous analysis step and used these measures as 
dependent variables in post hoc multiple regression ana-
lyses. We converted the variable coding for the 5 diagnostic 
groups into 4 dichotomous dummy variables using the HC 
group as the reference category. The same was done for the 
variable coding for the interaction effect (group X dimen-
sion). We included the resulting variables together with the 
dimensional factors and our covariates of no interest as in-
dependent variables into the regression model.
Control Analyses and Reliability Study
In order to address the challenges common to clinical im-
aging, we tested the robustness of the identified reward-
related activation and connectivity phenotypes in various 
control analyses. First, in order to target the potentially 
confounding effect of medication,33,34 we computed 
chlorpromazine dose equivalents (CPZ-e). However, as 
CPZ-e values only cover antipsychotic medication not 
taking into account other classes of medication, we ad-
ditionally calculated a standardized composite medica-
tion value following an established procedure for clinical 
studies that deal with different types of medication35 (see 
Supplementary Material for details). The resulting com-
posite scores and CPZ-e values (table 1) were subsequently 
related to second-level peak voxel estimates using partial 
correlation analyses in SPSS (IBM, SPSS, version 23). 
Second, to further ensure the robustness of our results 
with respect to imaging quality, we carefully balanced our 
sample for several QC parameters and performed partial 
correlation analyses to show that results were not related 
to head motion. Third, in order to investigate the effects 
of reward type (monetary vs social), we performed addi-
tional categorical and dimensional second-level analyses 
as outlined above using individual contrast images cap-
turing the interaction effect between condition and reward 
type (contrast: (win [social] > neutral [social]) > (neutral 
[monetary] > win [monetary]). Fourth, we tested for po-
tential influences of sex and current depressive state. See 
Supplementary Material for details, also for additional 
analyses and results for reward consumption.
Results
Diagnostic Group Differences
Compared to HC, we observed reduced vST activation 
during reward anticipation in SZ, BP, and ASD (PFWE 
< .05, small volume correction [SVC]) but not MD 
(figure  1; table  2). Beyond the vST, activation analyses 
revealed group differences in areas that have previously 
been linked to the executive control network, such as the 
inferior parietal lobule (IPL) and lateral prefrontal cortex 
(PFWE < .05, whole-brain corrected; figure  2A; table  2). 
Post hoc tests revealed that these effects were most pro-
nounced in BP compared to HC (table 2). In addition, we 
detected group differences in vST connectivity with the 
IPL and cerebellum (PFWE < .05, whole-brain corrected, 
Fig. 1. Categorical group differences in ventral striatum (vST) responses during reward anticipation (cue win vs neutral) and plotted 
contrast estimates (mean, SE) of the right vST. HC, healthy control; SZ, schizophrenia; BP, bipolar disorder; MD, major depression; 
ASD, autism spectrum disorder. For illustration, a significance threshold of Puncorr < .001 was applied.
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figure  2B; table  2), which were mainly driven by re-
duced functional connectivity in SZ and BP compared 
to HC (PFWE < .05, whole-brain corrected, Table 2). See 
Supplementary Material for details.
Extraction of Dimensional Measures
The factor-analytical approach revealed 3 uncorrelated 
factors covering aspects of affective, cognitive, and social 
functioning (see Supplementary Material and figure 3A). 
We refer to the first factor as affective instability because 
it is composed of diverse psychological constructs like 
anxiety, anhedonia, neuroticism, self-control, or impul-
sivity, all of which converge on difficulties to adequately 
regulate the affective state. The second factor includes 
different measures assessing neurocognitive performance 
(eg, memory and reasoning) and is referred to as cognitive 
functioning. The third factor specifically covers measures 
related to social traits and is referred to as social func-
tioning. Despite the existence of mean group differences 
(see Supplementary Material), both within-group vari-
ance and cross-group overlap suggest a broad distribu-
tion of each factor across disorders (figure 3A).
Association of Dimensional Measures with Brain 
Activity and Connectivity
Higher affective instability (factor 1) was associated with 
reduced vST activation, while higher cognitive and so-
cial functioning (factor 2 and 3)  were related to higher 
Table 2. Group differences and dimensional association
Region k x y z F/T Pcorr
Significant post hoc  
group differences
Categorical results
Activation
vST R* 69 12 8 −10 7.39 .001 HC > SZ, HC > BP,  
HC > ASD, MD > BP
vST L* 15 −12 5 −10 5.86 .009 HC > BP, HC > ASD
Inferior parietal lobule L (IPC [PGa]) 32 −39 −61 53 9.45 .007 HC > BP
Inferior parietal lobule R (IPC [PGp]) 23 33 −73 44 8.88 .017 HC > BP
Lateral frontal gyrus R (Area 45) 10 60 23 8 8.57 .026 HC > BP
vST—connectivity
Inferior parietal lobule R (SPL [7A]) 43 33 −58 53 12.61 <.001 HC > SZ, HC > BP
Fusiform L 34 −24 −70 −16 10.66 .002 HC > BP
Cerebellum R 19 24 −37 −37 9.56 .011 HC > SZ
Dimensional results
Activation
Factor 1: affective
Cerebellum L 40 −21 −76 −34 4.91 .009  
Lateral frontal gyrus R (Area 45) 51 57 20 17 4.91 .010  
Superior medial frontal gyrus 15 3 35 35 4.87 .011  
Superior medial frontal gyrus 12 3 29 53 4.52 .027  
vST R* 49 6 5 −1 4.58 <.001  
vST L* 13 −3 5 −1 3.44 .009  
Factor 2: cognitive
vST L* 9 −3 8 2 3.15 .020  
vST R* 8 6 8 5 3.11 .022  
Factor 3: social
vST R* 1 9 11 5 2.81 .049  
vST connectivity
Factor 1: affective
Postcentral gyrus L (Area 4a) 74 −30 −31 68 5.78 <.001  
Inferior parietal lobule R (SPL [7A]) 60 27 −55 50 5.89 <.001  
Superior parietal cortex L (SPL [7A]) 26 −18 −64 62 5.50 .001  
Cuneus L 130 −6 −85 32 5.47 .002  
Insula L (Insula [Id1]) 18 −36 −16 −4 5.42 .002  
Superior temporal cortex R (TE 3) 12 66 −22 14 5.39 .002  
Putamen L 15 −27 −4 2 5.18 .006  
Note: Cluster extent k is given at Pcorr < .05, familywise error (FWE) corrected for multiple comparisons within the whole brain for k > 
10 voxels or within the *ventral striatum (vST) region of interest (ROI) using small volume correction (SVC). x-, y-, and z-coordinates 
(MNI) and statistical information refer to the peak voxel(s) in the corresponding cluster (voxel-level statistics). In the following, we addi-
tionally report cluster-level statistics for vST ROI activation at an initial height threshold of Punorr = .001 and a cluster threshold of pcorr 
< .05, FWE corrected using SVC: categorical—right vST: k = 67, Pcorr = .002, categorical—left vST: k = 13, Pcorr = .015; factor 1—right 
vST: k = 35, Pcorr = .005, factor 1—left vST: k = 3, Pcorr = .016; factor 2—right vST: k = 0, factor 2—left vST: k = 1, Pcorr = .019; factor 
3—right vST: k = 0, factor 3—left vST: k = 0. R, right; L, left.
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vST activation (PFWE < .05, SVC; figure 3B; table 2). On 
the whole-brain level, higher affective instability (factor 
1) was associated with lower activation in lateral and me-
dial frontal areas as well as in the cerebellum (PFWE < .05, 
whole-brain corrected; table  2). No significant associa-
tion emerged for factors 2 and 3.  In addition, affective 
instability (factor 1)  was associated with reduced vST 
connectivity with visual and motor areas and in parietal 
regions, with prominent clusters in the IPL, insula, and 
putamen (figure 2C; table 2).
Post hoc multiple regression analyses revealed that in-
dividual factor loadings predicted vST activation beyond 
the effect of diagnostic group for affective instability 
(right vST: beta = −1.687, P = .044) and cognitive func-
tioning (left vST: beta = 1.307, P = .022), while the asso-
ciation with social functioning was trend-level significant 
(right vST: beta = .936, P = .070). The interaction effects 
between diagnostic group and factor loadings did not 
yield significant results (all P > .05). See Supplementary 
Material for details.
Control Analyses
Partial correlation analyses showed that overall results 
were not related to medication load, CPZ-e, or head mo-
tion. Furthermore, results were not differentially affected 
by reward type (monetary vs social), current depressive 
state (except for the expected association with factor 1), 
or sex. See Supplementary Material for details.
Discussion
This study aimed to confirm and extend current knowl-
edge about alterations in reward anticipation in severe 
mental disorders by systematically examining the rela-
tion to disorder categories and functional dimensions. 
Our results show that alterations in vST-related networks 
constitute transdiagnostic phenotypes that (1) relate to 
affective, cognitive, and social functioning across diag-
noses and (2) are associated with alterations in frontal 
and parietal regions likely involved in executive control.
vST response alterations between and across nosological 
boundaries
We replicated the finding of  reduced vST activation 
during reward anticipation in patients with SZ and dem-
onstrated similar alterations in BP and ASD, lending 
further evidence to the cross-diagnostic relevance of 
this phenotype.3 In contrast to some previous reports,5,6 
we did not find reduced vST responses in MD patients. 
Besides differences in medication and task design, this 
discrepancy might result from differences in current de-
pressive state, which ranged from fully remitted to cur-
rently depressed in our MD sample. State-dependent 
vST alterations11 might, therefore, be masked, al-
though this was not supported by our control ana-
lyses. Interestingly, however, our dimensional approach 
nonetheless suggests an impact of  affective functioning 
on reward processing, with higher affective instability 
Fig. 2. Whole-brain activation and connectivity results. Main effect of group for activation (A; cue win vs neutral) and ventral striatal 
(vST) seeded connectivity (B). (C) Negative association between affective instability and vST seeded connectivity with the right inferior 
parietal lobule (IPL). Bar plots depict respective contrast and seeded connectivity estimates (mean, SE) of the peak voxel in the right 
IPL. r, Pearson correlation coefficient; HC, healthy control; SZ, schizophrenia; BP, bipolar disorder; MD, major depression; ASD, 
autism spectrum disorder. For illustration, a significance threshold of Puncorr < .001 (cluster extent > 20) was applied.
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(factor 1) relating to lower responses in the vST across 
diagnostic entities including MD. While this adds to re-
cent transdiagnostic evidence,3,4,11 we additionally show 
that this association is valid for a broad definition of 
affective functioning based on a comprehensive col-
lection of  clinical measures representing diverse psy-
chological constructs associated with a general risk for 
psychiatric disorders.36 These observations suggest that 
a dysfunctional regulation of  affective symptoms relates 
to vST alterations across the psychiatric spectrum, likely 
reflecting blunted attribution of  motivational salience 
to rewarding stimuli.3
We also observed an association with a dimensional 
measure of cognitive functioning (factor 2)  where 
stronger vST responses related to better performance in 
neurocognitive tests. This suggests that cognitive deficits, 
Fig. 3. Dimensional results. (A) Group-specific factor loadings. (B) Scatter plots depict associations between peak voxel contrast 
estimates in the ventral striatum (vST) and dimensional factors relating to affective instability (left), cognitive functioning (middle), and 
social functioning (right). Linear fit lines in black color refer to the full sample, while group-specific linear fit lines are depicted in color. 
(C) Scatter plots display the partial correlation results between each factor and peak voxel contrast estimates in the vST while controlling 
for diagnostic group, age, sex, and education. r, Pearson correlation coefficient; HC, healthy control; SZ, schizophrenia; BP, bipolar 
disorder; MD, major depression; ASD, autism spectrum disorder. For illustration, images were masked with the predefined vST mask 
and a significance threshold of Puncorr < .005 was applied.
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such as deficits in working memory or cognitive flexi-
bility, are relevant to reward anticipation in the context 
of incentive delay tasks, which require a certain level 
of task comprehension and working memory capacity. 
Indeed, deficits in the ability to actively represent and 
maintain information about the task and the anticipated 
rewards have been suggested to contribute to blunted re-
ward experience and anhedonia in SZ.37 Here, we show 
that the relationship between striatal activation and cog-
nitive functioning is not specific to SZ but rather relates 
to the degree of cognitive impairment independent of di-
agnostic category.
Regarding social functioning (factor 3), higher scores 
related to higher vST responses, which was, however, not 
independent from diagnostic group. In fact, factor 3 was 
strongly driven by the ASD group. While a role of reward 
processing in ASD is well established,38 our dimensional 
analyses tentatively point to a transdiagnostic relation-
ship between social functioning and vST response to re-
ward anticipation.
In sum, our categorical approach suggests that vST 
functional alterations are present across several diagnostic 
categories. Moreover, our factor-analytical approach 
points to distinct brain-behavior relationships that exist 
across nosological boundaries. Supplemental analyses 
confirmed that the observed dimensional effects were not 
(factors 1 and 2) or only to a small extent (factor 3) ex-
plained by diagnostic category, emphasizing the higher 
sensitivity of our dimensional approach. This challenges 
more disorder-specific mechanistic theories of vST dys-
function (eg, aberrant salience processing in SZ39; anhe-
donia in MD5; alterations in the behavioral activation 
system in BP40; and social motivation deficits in ASD23) 
and points to shared underlying neural mechanisms that 
could, eg, relate to the participation of the vST in sepa-
rable processing loops.15 As the limited spatial resolution 
prevents a more fine-grained structural characterization 
of the activation pattern associated with each factor, fu-
ture studies should investigate whether the localization of 
peak voxels might reflect the well-established pattern of 
a dorsal-cognitive to ventral-affective gradient in the stri-
atum.15 Similarly, our supplemental finding of potential 
transdiagnostic alterations in the vST during reward re-
ceipt should be followed up using optimized task designs, 
eg, jittered target-receipt intervals and a higher number 
of trials allowing for the comparison of successful and 
nonsuccessful win trials.
Neural Networks Linked to Reward Processing
Beyond the vST, we adopted a brain-wide perspective 
to explore the distributed networks relevant for dimen-
sional or categorical effects of reward processing which 
converged on regions related to the frontoparietal net-
work (FPN), specifically on the IPL and prefrontal 
areas: Categorical whole-brain analyses revealed reduced 
brain responses in these regions, most prominently in BP 
for activation and in SZ and BP for vST connectivity. 
Dimensional analyses suggest higher affective instability 
(factor 1) to relate to lower responses in lateral prefrontal 
regions, as well as to reduced vST connectivity with 
the IPL.
Our observation of altered functional responses in re-
gions involved in executive control, in particular in BP 
and SZ patients, aligns with previous findings.41–48 In line 
with our results, a recent study showed that higher genetic 
risk for psychotic disorders was associated with aberrant 
integration of information across networks for attention 
(including the FPN) and the striatum,48 suggesting a dis-
rupted cross talk between the executive control and re-
ward network. Our dimensional approach additionally 
suggests that alterations in executive control areas con-
stitute a shared phenotype across nosological boundaries 
and relate to affective regulation deficits.
The importance of a tight interaction between the ex-
ecutive control and reward networks is well described.49,50 
Reward cues facilitate the allocation of processing re-
sources toward behaviorally important stimuli,51 which 
is reflected by increased FPN activation52–54 and connec-
tivity with the reward network.55 The observed associa-
tion of control network function with affective instability 
might reflect reduced processing capacities across psychi-
atric conditions as a result of affective symptom load. 
This interpretation follows a recent, transdiagnostic 
theory of psychiatric dysfunction22 which postulates that 
the experience and regulation of symptoms, such as de-
pressed mood or paranoid ideation, consumes cognitive 
resources and results in limited flexibility of large-scale 
control networks.
Strengths and Limitations
This study faced several challenges common to clinical 
imaging.24 We controlled for basic demographic variables 
and showed that neither CPZ-e nor total medication 
were related to striatal responses. We carefully balanced 
our sample for several quality parameters, showed that 
results were not related to motion, and demonstrated 
fair-to-good reliability of task effects in an independent 
test–retest sample. Our PCA approach comes with the 
limitation that resulting components depended on the 
specific test battery, which we addressed by a broad 
coverage of domains and assessments. Conversely, this 
approach offers several advantages for dimensional ana-
lyses: (1) the resulting components are maximally inde-
pendent, (2) do not rely on single, often disorder-specific 
clinical measures with low variance in healthy subjects, 
(3) do not focus on single psychopathological processes 
not considering other psychological variables, and (4) re-
duce the selection bias of single measures out of a large 
questionnaire and test battery, ie, usually acquired in clin-
ical studies.24
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Despite these efforts, we acknowledge that we cannot 
rule out the possibility of unaddressed influences of some 
confounders, in particular potential interaction effects of 
medication. This issue needs to be addressed in larger-
scale studies that allow for the comparison of medicated 
and unmedicated patients, favorably within and across 
diagnostic groups. In addition, the inclusion of other 
diagnostic groups known to show alterations in reward 
processing (eg, obsessive-compulsive disorder), the sys-
tematic consideration of current disease state (eg, current 
episode vs remission states in MD) and comorbidities 
(eg, type, number, lifetime vs concurrent), and a better 
matching of groups on demographic characteristics (eg, 
sex, age, and education) would have been desirable but 
were beyond the feasible scope of the present study. 
Finally, we did not correct for the number of tests re-
sulting from this complex research question in order to 
maximize sensitivity. Also, we acknowledge that our re-
sults might to some degree be influenced by the choice of 
analytical methods, such as preprocessing strategies, sta-
tistical models, and the choice of significance assessment 
(eg, voxel-level vs cluster-level significance).
However, while methodologically very challenging, our 
approach of jointly investigating different patient groups 
in the same study comes with the valuable advantage of 
ruling out methodological differences when comparing re-
sults between different diagnoses. Prospectively, there will 
be a need to conduct large-scale, preregistered, multisite 
and multidiagnosis research to overcome the heteroge-
neity of findings generated by smaller-sized studies.
Conclusion
The present study demonstrates reward-processing al-
terations in a range of psychiatric disorders. Using di-
mensional, behaviorally meaningful measures covering 
affective, cognitive, and social functioning, we further 
demonstrate that independent psychological domains 
relate to altered vST activation across the psychiatric 
spectrum, thereby informing current disorder-specific 
mechanistic theories of vST dysfunction. Beyond the 
vST, our results tentatively point to transdiagnostic alter-
ations in the interaction between the reward and executive 
control network, suggesting that the symptom-induced 
reduction of cognitive control capacities might constitute 
a superordinate transdiagnostic factor mediating domain 
specific differences such as blunted striatal functioning. 
Our results can inform the development of therapeutic 
interventions targeting specifically the enhancement of 
cognitive control abilities in mental disorders (eg, atten-
tional training techniques included in the metacognitive 
therapy56) and provide a biological account of the under-
lying pathophysiological landscape of mental illness that 
can inform both categorical and domain-related accounts 
of psychiatric nosology. Furthermore, our data indicate 
good reliability and robustness against common clinical 
confounders, indicating that similar measures may use-
fully contribute to biomarkers in the clinic and, thus, be 
useful in precision medicine approaches in psychiatry.
Supplementary Material
Supplementary data are available at Schizophrenia 
Bulletin online.
Acknowledgments
We thank Axel Schäfer, Michael Schneider, Dagmar Gass, 
Birgül Sarun, Claudia Stief, Natalie Hess, and Mirjam 
Melzer for research assistance. This study was performed 
at Central Institute of Mental Health.
Funding
This work was supported by the Bundesministerium für 
Bildung und Forschung (01ZX1314G, 01ZX1311B, and 
01GQ1102), the Seventh Framework Programme of 
the European Community (115300, Project EU-AIMS; 
602805, Project EU-AGGRESSOTYPE; 602450, 
Project EU-IMAGEMEND), and the Deutsche 
Forschungsgemeinschaft (5485966 and 539/3-1). A.M.-L. 
further acknowledges grant support by the Deutsche 
Forschungsgemeinschaft (Collaborative Research Center 
SFB 1158 subproject B09, Collaborative Research 
Center TRR 265 subproject S02, Clinical Research 
Unit KFO 256 subproject IP3,  grant ME 1591/4-1) 
and Bundesministerium für Bildung und Forschung 
(grants 01EF1803A, 01ZX1314G, 01GQ1003B) and 
HEALTH-F2-2010-241909, Innovative Medicines 
Initiative Joint Undertaking (grant 115008) and 
Ministerium für Wissenschaft, Forschung und Kunst 
Baden-Württemberg (grant 42-04HV.MED(16)/16/1). 
H.T. further acknowledges grant support by the Deutsche 
Forschungsgemeinschaft (Collaborative Research Center 
SFB 1158 subproject B04, Collaborative Research Center 
TRR 265 subproject A04, Research Training Group 
GRK2350/1 subproject B02) and Bundesministerium 
für Bildung und Forschung (grants 01EF1803A project 
WP3, 01GQ1102). C.M. is a recipient of the Olympia-
Morata grant of the University Heidelberg.
Conflict of Interest statement
K.S., C.M., J.S., S.B., M.P., C.W., S.E., H.W., and 
H.T.  have nothing to declare. D.B.  serves as an unpaid 
scientific consultant for an EU-funded neurofeedback 
trial. T.B.  served in an advisory or consultancy role 
for Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, 
Neurim Pharmaceuticals, Novartis, and Shire. He re-
ceived conference support or speaker’s fee by Lilly, 
Medice, Novartis, and Shire. He has been involved in 
clinical trials conducted by Shire & Viforpharma. He re-
ceived royalities from Hogrefe, Kohlhammer, CIP Medien, 
D
ow
nloaded from
 https://academ
ic.oup.com
/schizophreniabulletin/advance-article-abstract/doi/10.1093/schbul/sbz075/5581768 by U
niversitaetsbibliothek Bern user on 04 N
ovem
ber 2019
Page 10 of 11
K. Schwarz et al 
Oxford University Press. The present work is unrelated to 
the above grants and relationships. A.M.-L. has received 
consultant fees from Boehringer Ingelheim, Elsevier, Walt 
Disney Pictures, Brainsway, Lundbeck Int. Neuroscience 
Foundation, Sumitomo Dainippon Pharma Co., Academic 
Medical Center of the University of Amsterdam, 
Synapsis Foundation-Alzheimer Research Switzerland, 
IBS Center for Synaptic Brain Dysfunction, Blueprint 
Partnership, University of Cambridge, Dt. Zentrum für 
Neurodegenerative Erkrankungen, Universität Zürich, 
L.E.K. Consulting, ICARE Schizophrenia, Science 
Advances, and has received fees for lectures, interviews and 
travels from Lundbeck International Foundation, Paul-
Martini-Stiftung, Lilly Deutschland, Atheneum, Fama 
Public Relations, Institut d’investigacions Biomèdiques 
August Pi i Sunyer (IDIBAPS), Jansen-Cilag, Hertie 
Stiftung, Bodelschwingh-Klinik, Pfizer, Atheneum, 
Universität Freiburg, Schizophrenia Academy, Hong Kong 
Society of Biological Psychiatry, Fama Public Relations, 
Spanish Society of Psychiatry, Reunions I  Ciencia S.L., 
Brain Center Rudolf Magnus UMC Utrecht.
References
 1. Radua J, Schmidt A, Borgwardt S, et al. Ventral striatal activa-
tion during reward processing in psychosis: a neurofunctional 
meta-analysis. JAMA Psychiatry. 2015;72(12):1243–1251.
 2. Whitton  AE, Treadway  MT, Pizzagalli  DA. Reward 
processing dysfunction in major depression, bipolar disorder 
and schizophrenia. Curr Opin Psychiatry. 2015;28(1):7–12.
 3. Hägele  C, Schlagenhauf  F, Rapp  M, et  al. Dimensional 
psychiatry: reward dysfunction and depressive mood 
across psychiatric disorders. Psychopharmacology (Berl). 
2015;232(2):331–341.
 4. Arrondo  G, Segarra  N, Metastasio  A, et  al. Reduction in 
ventral striatal activity when anticipating a reward in depres-
sion and schizophrenia: a replicated cross-diagnostic finding. 
Front Psychol. 2015;6:1280.
 5. Zhang  WN, Chang  SH, Guo  LY, Zhang  KL, Wang  J. The 
neural correlates of reward-related processing in major de-
pressive disorder: a meta-analysis of functional magnetic res-
onance imaging studies. J Affect Disord. 2013;151(2):531–539.
 6. Keren  H, O’Callaghan  G, Vidal-Ribas  P, et  al. Reward 
processing in depression: a conceptual and meta-analytic 
review across fMRI and EEG studies. Am J Psychiatry. 
2018;175(11):1111–1120.
 7. Nusslock R, Almeida JR, Forbes EE, et al. Waiting to win: 
elevated striatal and orbitofrontal cortical activity during re-
ward anticipation in euthymic bipolar disorder adults. Bipolar 
Disord. 2012;14(3):249–260.
 8. Dichter GS, Felder JN, Green SR, Rittenberg AM, Sasson NJ, 
Bodfish  JW. Reward circuitry function in autism spectrum 
disorders. Soc Cogn Affect Neurosci. 2012;7(2):160–172.
 9. Cross-Disorder Group of the Psychiatric Genomics Consortium 
C-DG of the PG. Identification of risk loci with shared effects 
on five major psychiatric disorders: a genome-wide analysis. 
Lancet (London, England). 2013;381(9875):1371–1379.
 10. Nielsen  MØ, Rostrup  E, Wulff  S, et  al. Alterations of the 
brain reward system in antipsychotic naïve schizophrenia pa-
tients. Biol Psychiatry. 2012;71(10):898–905.
 11. Satterthwaite TD, Kable JW, Vandekar L, et al. Common and dis-
sociable dysfunction of the reward system in bipolar and unipolar 
depression. Neuropsychopharmacology. 2015;40(9):2258–2268.
 12. Cuthbert  BN. The RDoC framework: facilitating transi-
tion from ICD/DSM to dimensional approaches that inte-
grate neuroscience and psychopathology. World Psychiatry. 
2014;13(1):28–35.
 13. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria 
(RDoC): toward a new classification framework for research 
on mental disorders. Am J Psychiatry. 2010;167(7):748–751.
 14. Howes  OD, Kapur  S. The dopamine hypothesis of schizo-
phrenia: version III–the final common pathway. Schizophr 
Bull. 2009;35(3):549–562.
 15. Haber  SN, Knutson  B. The reward circuit: linking primate 
anatomy and human imaging. Neuropsychopharmacology. 
2010;35(1):4–26.
 16. Báez-Mendoza R, Schultz W. The role of the striatum in so-
cial behavior. Front Neurosci. 2013;7:233.
 17. Tu PC, Hsieh JC, Li CT, Bai YM, Su TP. Cortico-striatal dis-
connection within the cingulo-opercular network in schizo-
phrenia revealed by intrinsic functional connectivity analysis: 
a resting fMRI study. Neuroimage. 2012;59(1):238–247.
 18. Vargas C, López-Jaramillo C, Vieta E. A systematic literature 
review of resting state network–functional MRI in bipolar 
disorder. J Affect Disord. 2013;150(3):727–735.
 19. Fischer  AS, Keller  CJ, Etkin  A. The Clinical applicability 
of functional connectivity in depression: pathways toward 
more targeted intervention. Biol Psychiatry Cogn Neurosci 
Neuroimaging. 2016;1(3):262–270.
 20. Delmonte  S, Gallagher  L, O’Hanlon  E, McGrath  J, 
Balsters  JH. Functional and structural connectivity of 
frontostriatal circuitry in autism spectrum disorder. Front 
Hum Neurosci. 2013;7:430.
 21. Sharma  A, Wolf  DH, Ciric  R, et  al. Common dimen-
sional reward deficits across mood and psychotic disorders: 
a connectome-wide association study. Am J Psychiatry. 
2017;174(7):657–666.
 22. Cole MW, Repovš G, Anticevic A. The frontoparietal con-
trol system: a central role in mental health. Neuroscientist. 
2014;20(6):652–664.
 23. Chevallier C, Kohls G, Troiani V, Brodkin ES, Schultz RT. 
The social motivation theory of autism. Trends Cogn Sci. 
2012;16(4):231–239.
 24. Greene DJ, Black KJ, Schlaggar BL. Considerations for MRI 
study design and implementation in pediatric and clinical 
populations. Dev Cogn Neurosci. 2016;18:101–112.
 25. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical 
Interview for DSM-IV-TR Axis I Disorders, Research Version, 
Patient Edition with Psychotic Screen (SCID-I/P W/ PSY 
SCREEN). New York, NY: New York State Psychiatric 
Institute; 2001.
 26. Lord C, Rutter M, DiLavore P, Risi S. The Autism Diagnostic 
Observation Schedule (Ados). Los Angeles, CA: Western 
Psychological Corporation; 1999.
 27. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation 
of increasing monetary reward selectively recruits nucleus 
accumbens. J Neurosci. 2001;21(16):RC159.
 28. Kirsch  P, Schienle  A, Stark  R, et  al. Anticipation of re-
ward in a nonaversive differential conditioning paradigm 
and the brain reward system: an event-related fMRI study. 
Neuroimage. 2003;20(2):1086–1095.
 29. Spreckelmeyer KN, Krach S, Kohls G, et al. Anticipation of 
monetary and social reward differently activates mesolimbic 
D
ow
nloaded from
 https://academ
ic.oup.com
/schizophreniabulletin/advance-article-abstract/doi/10.1093/schbul/sbz075/5581768 by U
niversitaetsbibliothek Bern user on 04 N
ovem
ber 2019
Page 11 of 11
Reward anticipation across the psychiatric spectrum
brain structures in men and women. Soc Cogn Affect Neurosci. 
2009;4(2):158–165.
 30. Lin A, Adolphs R, Rangel A. Social and monetary reward 
learning engage overlapping neural substrates. Soc Cogn 
Affect Neurosci. 2012;7(3):274–281.
 31. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. 
Spurious but systematic correlations in functional connect-
ivity MRI networks arise from subject motion. Neuroimage. 
2012;59(3):2142–2154.
 32. Plichta  MM, Schwarz  AJ, Grimm  O, et  al. Test-retest reli-
ability of evoked BOLD signals from a cognitive-emotive 
fMRI test battery. Neuroimage. 2012;60(3):1746–1758.
 33. Abler  B, Erk  S, Walter  H. Human reward system acti-
vation is modulated by a single dose of  olanzapine in 
healthy subjects in an event-related, double-blind, placebo-
controlled fMRI study. Psychopharmacology (Berl). 
2007;191(3):823–833.
 34. Stoy M, Schlagenhauf F, Sterzer P, et al. Hyporeactivity of 
ventral striatum towards incentive stimuli in unmedicated de-
pressed patients normalizes after treatment with escitalopram. 
J Psychopharmacol. 2012;26(5):677–688.
 35. Hassel  S, Almeida  JR, Kerr  N, et  al. Elevated striatal and 
decreased dorsolateral prefrontal cortical activity in response 
to emotional stimuli in euthymic bipolar disorder: no asso-
ciations with psychotropic medication load. Bipolar Disord. 
2008;10(8):916–927.
 36. Jeronimus BF, Kotov R, Riese H, Ormel J. Neuroticism’s pro-
spective association with mental disorders halves after adjust-
ment for baseline symptoms and psychiatric history, but the 
adjusted association hardly decays with time: a meta-analysis 
on 59 longitudinal/prospective studies with 443 313 partici-
pants. Psychol Med. 2016;46(14):2883–2906.
 37. Barch DM. The relationships among cognition, motivation, 
and emotion in schizophrenia: how much and how little we 
know. Schizophr Bull. 2005;31(4):875–881.
 38. Clements  CC, Zoltowski  AR, Yankowitz  LD, Yerys  BE, 
Schultz RT, Herrington JD. Evaluation of the social motiv-
ation hypothesis of autism: a systematic review and meta-
analysis. JAMA Psychiatry. 2018;75(8):797–808.
 39. Gradin VB, Waiter G, O’Connor A, et al. Salience network-
midbrain dysconnectivity and blunted reward signals in 
schizophrenia. Psychiatry Res. 2013;211(2):104–111.
 40. Urosević  S, Abramson  LY, Harmon-Jones  E, Alloy  LB. 
Dysregulation of the behavioral approach system (BAS) in 
bipolar spectrum disorders: review of theory and evidence. 
Clin Psychol Rev. 2008;28(7):1188–1205.
 41. Urošević  S, Luciana  M, Jensen  JB, Youngstrom  EA, 
Thomas  KM. Age associations with neural processing of 
reward anticipation in adolescents with bipolar disorders. 
Neuroimage Clin. 2016;11:476–485.
 42. Meyer-Lindenberg  A, Miletich  RS, Kohn  PD, et  al. 
Reduced prefrontal activity predicts exaggerated striatal 
dopaminergic function in schizophrenia. Nat Neurosci. 
2002;5(3):267–271.
 43. Orliac  F, Naveau  M, Joliot  M, et  al. Links among 
resting-state default-mode network, salience network, 
and symptomatology in schizophrenia. Schizophr Res. 
2013;148(1-3):74–80.
 44. Sarpal  DK, Robinson  DG, Lencz  T, et  al. Antipsychotic 
treatment and functional connectivity of the striatum in first-
episode schizophrenia. JAMA Psychiatry. 2015;72(1):5–13.
 45. Anand A, Li Y, Wang Y, Lowe MJ, Dzemidzic M. Resting 
state corticolimbic connectivity abnormalities in unmedicated 
bipolar disorder and unipolar depression. Psychiatry Res. 
2009;171(3):189–198.
 46. Dutra  SJ, Man  V, Kober  H, Cunningham  WA, Gruber  J. 
Disrupted cortico-limbic connectivity during reward processing 
in remitted bipolar I disorder. Bipolar Disord. 2017;19(8):661–675.
 47. Ongür D, Lundy M, Greenhouse I, et al. Default mode net-
work abnormalities in bipolar disorder and schizophrenia. 
Psychiatry Res. 2010;183(1):59–68.
 48. Diwadkar  VA, Bakshi  N, Gupta  G, Pruitt  P, White  R, 
Eickhoff  SB. Dysfunction and dysconnection in cortical-
striatal networks during sustained attention: genetic risk for 
schizophrenia or bipolar disorder and its impact on brain net-
work function. Front Psychiatry. 2014;5:50.
 49. Pessoa L. Multiple influences of reward on perception and 
attention. Vis Cogn. 2015;23(1–2):272–290.
 50. Braver  TS, Krug  MK, Chiew  KS, et  al; MOMCAI group. 
Mechanisms of motivation-cognition interaction: challenges and 
opportunities. Cogn Affect Behav Neurosci. 2014;14(2):443–472.
 51. Redgrave P, Gurney K. The short-latency dopamine signal: 
a role in discovering novel actions? Nat Rev Neurosci. 
2006;7(12):967–975.
 52. Small DM, Gitelman D, Simmons K, Bloise SM, Parrish T, 
Mesulam  MM. Monetary incentives enhance processing in 
brain regions mediating top-down control of attention. Cereb 
Cortex. 2005;15(12):1855–1865.
 53. Mohanty  A, Gitelman  DR, Small  DM, Mesulam  MM. 
The spatial attention network interacts with limbic and 
monoaminergic systems to modulate motivation-induced at-
tention shifts. Cereb Cortex. 2008;18(11):2604–2613.
 54. Gilbert  AM, Fiez  JA. Integrating rewards and cogni-
tion in the frontal cortex. Cogn Affect Behav Neurosci. 
2004;4(4):540–552.
 55. Camara E, Rodriguez-Fornells A, Ye Z, Münte TF. Reward 
networks in the brain as captured by connectivity measures. 
Front Neurosci. 2009;3(3):350–362.
 56. Wells A, Simons M. Metacognitive therapy. In: Hofmann SG, 
ed. The Wiley Handbook of Cognitive Behavioral Therapy. 
Chichester, UK: John Wiley & Sons, Ltd; 2013:1–24.
 57. Guy W. ECDEU -Assessment Manual for Psychopharmacology. 
DHEW Pub. No. (ADM) 76–338. Rockville, MD: National 
Institute of Mental Health; 1976.
 58. Kay  SR, Fiszbein  A, Opler  LA. The positive and negative 
syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 
1987;13(2):261–276.
 59. Hamilton M. Development of a rating scale for primary de-
pressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.
 60. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale 
for mania: reliability, validity and sensitivity. Br J Psychiatry. 
1978;133:429–435.
 61. Hautzinger M, Keller F, Kühner C. Beck Depressions-Inventar 
(BDI-II). Revision. Frankfurt/Main, Germany: Harcourt 
Test Services; 2006.
D
ow
nloaded from
 https://academ
ic.oup.com
/schizophreniabulletin/advance-article-abstract/doi/10.1093/schbul/sbz075/5581768 by U
niversitaetsbibliothek Bern user on 04 N
ovem
ber 2019
